The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

OXP OXFORD PHARMASCIENCE GROUP PLC ORD 0.1P



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  0.12 0.28 0.47 1.03 0.71
Operating Profit/(Loss)  -0.83 -0.94 -0.82 -1.56 -3.50
Net Interest  0.00 0.00 0.00 0.00 0.00
Profit Before Tax  -0.83 -0.94 -0.82 -1.54 -3.46
Profit After Tax  -0.81 -0.93 -0.78 -1.49 -2.86
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -0.81 -0.93 -0.78 -1.49 -2.86
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -0.81 -0.93 -0.78 -1.49 -2.86
 
Continuing EPS
Earnings per Share - Basic  -0.18p -0.19p -0.13p -0.17p -0.29p
Earnings per Share - Diluted  -0.18p -0.19p -0.13p -0.17p -0.29p
Earnings per Share - Adjusted  -0.18p -0.19p -0.13p -0.17p -0.29p
Continuing and Discontinued EPS
Earnings per Share - Basic  -0.18p -0.19p -0.13p -0.17p -0.29p
Earnings per Share - Diluted  -0.18p -0.19p -0.13p -0.17p -0.29p
Earnings per Share - Adjusted  -0.18p -0.19p -0.13p -0.17p -0.29p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  0.01 0.01 0.01 0.01 0.01
Intangible Assets  0.08 0.07 0.06 0.05 0.04
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  0.09 0.07 0.06 0.06 0.05
Current Assets
Inventories  0.10 0.04 0.04 0.02 0.02
Trade & Other Receivables  0.07 0.16 0.20 0.25 0.84
Cash at Bank & in Hand  0.90 1.11 2.22 9.94 6.71
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  1.07 1.31 2.46 10.21 7.56
 
Total Assets  1.16 1.38 2.52 10.27 7.61
 
Liabilities
Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Other Current Liabilities  -0.06 -0.13 -0.14 -0.37 -0.29
  -0.06 -0.13 -0.14 -0.37 -0.29
 
Net Current Assets  1.01 1.18 2.32 9.84 7.27
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  0.00 0.00 0.00 0.00 0.00
Other Non-Current Liabilities  0.00 0.00 0.00 0.00 0.00
  0.00 0.00 0.00 0.00 0.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -0.06 -0.13 -0.14 -0.37 -0.29
 
Net Assets  1.10 1.25 2.39 9.90 7.32
 
Capital & Reserves
Share Capital  0.46 0.58 0.73 1.00 1.01
Share Premium Account  1.04 2.00 3.76 12.42 12.57
Other Reserves  0.74 -1.32 -2.10 -3.52 -6.26
Retained Earnings  -1.15 0.00 0.00 0.00 0.00
Shareholders Funds  1.10 1.25 2.39 9.90 7.32
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  1.10 1.25 2.39 9.90 7.32

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  n/a -6.71 -16.15 -22.21 -11.81
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  0.03p 0.06p 0.08p 0.12p 0.07p
Pre-Tax Profit per Share  -0.18p -0.20p -0.14p -0.18p -0.35p
Operating Margin  -674.80% -331.91% -175.97% -151.41% -495.89%
Return on Capital Employed  -81.77% -79.05% -35.15% -15.60% -47.60%
 
Continuing & Discontinued Operations
Dividend Yield  n/a 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  0.22p 0.21p 0.32p 0.99p 0.72p
Net Gearing  -81.83% -88.26% -92.96% -100.41% -91.61%

Data is provided by Morningstar


Company Information
Updated Monthly
Company address Weston House, Bradgate Park View, Chellaston, Derby, DE73 5UJ, United Kingdom
Company website http://www.oxfordpharma...
Market cap(in millions)* £ 96.45
Listing/Admission to trading 12 Feb 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
29-Aug-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 75,000
SEDOL B3LXPB4
ISIN number GB00B3LXPB43



OXFORD PHARM GP share - fundamentals